Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Research Notes

Open Access

Rhabdomyolysis presenting with severe hypokalemia in hypertensive patients: a case series

BMC Research Notes20136:155

https://doi.org/10.1186/1756-0500-6-155

Received: 23 July 2012

Accepted: 3 April 2013

Published: 17 April 2013

Abstract

Background

Rhabdomyolysis presenting with severe hypokalemia as the first manifestation of primary hyperaldosteronism is extremely rare.

Case presentation

Two middle-aged Chinese females were admitted to our emergency department for muscular weakness and limb pain, and both have the history of early onset hypertension. Laboratory test showed elevated creatinine phosphokinase (4, 907 and 8, 531 IU/L) and extremely low serum potassium (1.38 mmol/L and 1.98 mmol/L). Rhabdomyolysis and severe hypokalemia were established as first diagnosis. Hypokalemic rhabdomyolysis was confirmed after nervous system disorders, autoimmune diseases and trauma were excluded. Adrenal computerized tomography scan and postural stimulation test revealed aldosterone-producing adenomas. They both received laparoscopic adrenalectomy and were stable at the 2-year follow-up visit.

Conclusion

The two cases remind physicians to bear in mind the risk of hypokalemia-induced rhabdomyolysis among patients with primary hyperaldosteronism.

Background

Primary hyperaldosteronism (PHA) is a common cause of secondary hypertension. The main clinical manifestations are resistant hypertension and hypokalemia. Hypokalemia induced by PHA is a chronic process and most patients can tolerant the symptoms of malaise, muscular weakness and fatigability. But in some extreme conditions, PHA can induce excessive potassium excretion followed by rhabdomyolysis. Rhabdomyolysis presenting with severe hypokalemia as the first manifestation is rare in primary hyperaldosteronism. We report two cases of PHA diagnosed successfully.

Case presentation

Case 1

A 45-year-old Chinese female presented herself with fatigue and limb pain since 10 days in the emergency department. A slight pain in the right femoribus internus gradually aggravated in severity and extent during the following 10 days, and progressively got the upper limbs, back and neck involved in. She reported about a four-year history of arterial hypertension treated with nitrendipine and captopril. She denied any acute infections, trauma or intoxication. Physical examination revealed slightly elevated blood pressure (143/80 mmHg) and tenderness in the limb muscles. The laboratory examinations (Table 1) showed extremely low serum potassium (1.38 mmol/L) and elevated CPK (4, 907 IU/L). Electrocardiogram (ECG) showed Q-T interval elongation and abnormal U wave.
Table 1

Laboratory data on admission

 

Case 1

Case 2

Urinalysis

 

pH

8.00

7.00

glucose

-

-

protein

-

-

ketone

-

-

CBC

 

WBC

11.40 × 109/L

8.38 × 109/L

RBC

4.71 × 1012/L

4.68 × 1012/L

Hb

129 g/L

139 g/L

Hct

0.39 L/L

0.39 L/L

Plt

158 × 109/L

255 × 109/L

Blood Chemistry

 

Alb

47.1 g/L

37.4 g/L

TBIL

17.0 umol/L

13.8 umol/L

ALT

61 IU/L

46 IU/L

AST

123 IU/L

115 IU/L

GLU

6.56 mmol/L

5.33 mmol/L

BUN

7.15 mmol/L

2.69 mmol/L

Cre

92.7 umol/L

58.8 umol/L

UA

297.5 umol/L

176.0 umol/L

Myo

28.28 ng/ml

 

CHOL

4.56 mmol/L

4.00 mmol/L

TG

1.63 mmol/L

2.94 mmol/L

HDL-C

1.56 mmol/L

0.83 mmol/L

CK

4907 IU/L

8531 IU/L

LDH

477 IU/L

335 IU/L

Na

142.1 mmol/L

146.0 mmol/L

K

1.38 mmol/L

1.98 mmol/L

Cl

98.7 mmol/L

97.8 mmol/L

Arterial Blood Gas Analysis on Room Air

 

pH

7.432

7.487

pO2

72.0 mmHg

75.2 mmHg

pCO2

37.4 mmHg

43.1 mmHg

HCO3-

24.4 mmol/L

31.9 mmol/L

BE

0.4 mmol/L

mmol/L

Based upon these clinical features, we established hypokalemia and rhabdomyolysis as first diagnosis. A series of laboratory examinations were performed for differential diagnosis of rhabdomyolysis. Biopsy results of right biceps brachii muscle revealed degenerated and necrotic muscle fibers with some inflammatory cells infiltrating the perimysium. The electromyogram was normal, which excluded nervous system disorders. Rhabdomyolysis induced by autoimmune diseases were excluded for negative results of autoimmune antibodies.

Hence, we supposed hypokalemia induces rhabdomyolysis. Tests for synchronous serum and urine potassium (First time: serum potassium 3.10 mmol/L, urine potassium 57.98 mmol/24 h; Second time: serum potassium 2.87 mmol/L, urine potassium 48.63 mmol/24 h) illustrated excessive potassium loss. Normal pH in arterial blood eliminated the suspect of renal tubule diseases.

High dose oral potassium supplementation was initiated. Pain and weakness were relieved and serum CPK levels normalized within one week. However, the serum potassium level remained low (3.00 mmol/L) despite potassium supplementation.

Increased Aldosterone to Renin ration (ARR) indicated PHA (See Table 2 and Figure 1). Adrenal imaging with computerized tomography (CT) scan showed a low-density mass measuring 2.1 cm in diameter in the left adrenal (Figure 2). After initiation of spironolactone treatment, blood pressure and potassium levels in serum and urine returned to normal within one week.
Figure 1

Adrenal imaging of case 1. Nodular mass (diameter approximately 21 mm) on the left adrenal gland, and the right adrenal gland appears normal.

Figure 2

Adrenal histology of case 1. Fine connective tissue septa separate adrenal cortical clear cells nodules and the histopathology of resected specimen shows adenoma (HE × 100 and HE × 400).

Table 2

Endocrine test results

 

Case 1

Case 2

Reference range

 

Basal endocrine data: before postural stimulation test

PRA

0.84

0.07

0.05-0.84

ng/ml.h

AT-II

28.61

43.63

28.2-52.2

ng/L

PAC

639.38

449.70

45-175

ng/L

ARR

76.12

642.43

 

ng/dl:ng

NE

<50

59

174-357

ng/L

E

<50

<25

60-104

ng/L

TSH

4.180

6.360

0.27-4.2

mU/L

T3

2.21

 

1.3-3.1

nmol/L

T4

129.30

 

62-164

nmol/L

FT3

 

4.42

3.60-7.50

pmol/L

FT4

 

17.59

12.0-22.0

pmol/L

Endocrine data: 2 hours after postural stimulation test

PRA

 

0.17

0.56-2.79

ng/ml.h

AT-II

 

49.54

29.0-71.6

ng/L

PAC

 

265.80

98-275

ng/L

Case 2

Another Chinese female with 44 years old was admitted to our hospital with similar symptoms and signs of fatigue and limbs pain. Serum potassium was 1.98 mmol/L with highly elevated serum CPK levels (8, 531 IU/L). ECG showed highly elongated Q-T interval and abnormal apparent U wave. Differential work-up for hypokalemia and rhabdomyolysis showed PHA was the diagnosis (see Table 2 and Figure 1). CT scan revealed an adrenal gland mass with 1.6 cm in diameter (Figure 3). Symptoms were relieved after treatment with potassium and spironolactone.
Figure 3

Adrenal imaging of case 2. Nodular mass (diameter approximately 16 mm) on the left adrenal gland.

Both patients were treated with laparoscopic left adrenalectomy. Postural stimulation test and adrenal histology showed aldosterone-producing adenomas (Table 2 and Figure 4). Until the two year follow-up visit, the patients did not complain about similar symptoms anymore, and the blood pressures and potassium levels remained in a normal range.
Figure 4

Adrenal histology of case 2. Adrenal cortical clear cells nodules is around by fine connective tissue septa and the histopathology of resected specimen shows adenoma (HE × 100 and HE × 400).

Discussion

Rhabdomyolysis is defined as a pathological condition of skeletal muscle cell damage leading to the release of toxic intracellular material into the blood circulation, such as CPK, myoglobin, aspartate aminotransferase, alanine aminotransferase and potassium [13]. The syndrome generally presents with the triad muscular pain, weakness and reddish brown urine [4].

The major causes of rhabdomyolysis include trauma, ischemia, drugs, toxins, metabolic disorders, infections and electrolyte disorders [5, 6]. Especially, severe hypokalemia might play an important role in muscle cell damage [7, 8]. Local potassium levels in capillaries are important regulators for vascular tension. Severe hypokalemia contracted capillaries, reduced muscle blood supply and finally resulting in lysing muscle cells and muscle cell damage [9, 10]. Frank rhabdomyolysis usually occurs only when serum potassium values are below 2.0 mmol/L [8, 11], which possibly induces cardiac arrhythmia and needs emergency treatment.

In PHA, aldosterone excess leads to water-sodium retention and potassium excretion. Patients usually present with hypertension and mild hypokalemia, while malaise and muscular weakness is always tolerable for patients. When vomiting or diarrhea occur or diuretics are used, serum potassium levels might drop to very low levels [12].

Although rhabdomyolysis usually results in hyperkalemia due to the direct release of intracellular potassium into the extracellular fluid, over-excreted aldosterone in PHA induces potassium excretion into urine. These mechanisms might be the reason we find hypokalemia, instead of hyperkalemia, resulting from rhabdomyolysis in those two cases.

Conclusion

The diagnosis of PHA might be difficult when rhabdomyolysis and severe hypokalemia are the first manifestation. However, when rhabdomyolysis and hypokalemia occur in hypertensive patients, PHA should be considered. Further investigation for PHA should be initiated.

Consent

Written informed consent was obtained from the patients for publication of this manuscript and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Declarations

Acknowledgements

ZHANG L and HE W revised the manuscript critically for intellectual content. Most importantly, We would like to thank the patients.

Authors’ Affiliations

(1)
Department of Respiratory, West China Hospital, Sichuan University
(2)
Department of Cardiology, Daping Hospital, The Third Military Medical University
(3)
Department of Endocrinology, West China Hospital, Sichuan University

References

  1. Vanholder R, Sever MS, Erek E, Lameire N: Rhabdomyolysis. J Am Soc Nephrol. 2000, 11: 1553-61.PubMedGoogle Scholar
  2. Beetham R: Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem. 2000, 37: 581-7. 10.1258/0004563001899870.PubMedView ArticleGoogle Scholar
  3. Singh D, Chander V, Chopra K: Rhabdomyolysis. Methods Find Exp Clin Pharmacol. 2005, 27: 39-48. 10.1358/mf.2005.27.1.875435.PubMedView ArticleGoogle Scholar
  4. Warren JD, Blumbergs PC, Thompson PD: Rhabdomyolysis: a review. Muscle Nerve. 2002, 25: 332-47. 10.1002/mus.10053.PubMedView ArticleGoogle Scholar
  5. Huang LY, Lin CM, Chiou CC, Lin WS, Cheng SM: Rhabdomyolysis as a potential complication of carbamazepine-induced toxic epidermal necrolysis. Clin Biochem. 2012, [Epub ahead of print]Google Scholar
  6. Knochel JP: Mechanisms of rhabdomyolysis. Curr Opin Rheumatol. 1993, 5: 725-731. 10.1097/00002281-199305060-00006.PubMedView ArticleGoogle Scholar
  7. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006, 48: 2293-2300. 10.1016/j.jacc.2006.07.059.PubMedView ArticleGoogle Scholar
  8. Knochel JP, Schlein EM: On the mechanism of rhabdomyolysis in potassium depletion. J Clin Invest. 1972, 51: 1750-8. 10.1172/JCI106976.PubMedPubMed CentralView ArticleGoogle Scholar
  9. Allison RC, Bedsole DL: The other medical causes of rhabdomyolysis. Am J Med Sci. 2003, 326: 79-88. 10.1097/00000441-200308000-00005.PubMedView ArticleGoogle Scholar
  10. Lin SH, Davids MR, Halperin ML: Hypokalemia and paralysis. Q J Med. 2003, 96: 161-9. 10.1093/qjmed/hcg021.View ArticleGoogle Scholar
  11. de Wolff JF: Rhabdomyolysis. Br J Hosp Med (Lond). 2012, 73: C30-2.View ArticleGoogle Scholar
  12. Goto A, Takahashi Y, Kishimoto M, Minowada S, Aibe H, Hasuo K, Kajio H, Noda M: Primary Aldosteronism Associated with Severe Rhabdomyolysis Due to Profound Hypokalemia. Intern Med. 2009, 48: 219-223. 10.2169/internalmedicine.48.1444.PubMedView ArticleGoogle Scholar

Copyright

© Wen et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement